Market Cap 220.05M
Revenue (ttm) 194.06M
Net Income (ttm) 14.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 7.39%
Debt to Equity Ratio 0.00
Volume 1,007,400
Avg Vol 1,090,332
Day's Range N/A - N/A
Shares Out 48.36M
Stochastic %K 33%
Beta 1.98
Analysts Strong Sell
Price Target $9.88

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services
Sector: Healthcare
Phone: 866 351 5907
Website: lifemd.com
Address:
236 Fifth Avenue, Suite 400, New York, United States
alphawolftrading
alphawolftrading Jun. 23 at 10:21 PM
$LFMD I just sat down again with LifeMD (NASDAQ: LFMD) Co‑Founder & CEO Justin Schreiber for a deep dive into how they’re building a full‑stack virtual healthcare and pharmacy platform – not just a GLP‑1 story. We cover their revamped leadership team, the LifeMD+ $19/month membership model for 24/7 primary and urgent care, upcoming Medicare GLP‑1 access at a $50 copay, and how AI, women’s and men’s health, metabolic programs, and personalized compounding fit into LifeMD’s next phase of growth. https://youtu.be/SfvC-JAFO4M
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 9:36 PM
$LFMD Back to the 3s like it never left. Does anyone here have a legitimate bull case that they can kindly share ?
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 2:09 PM
0 · Reply
Annaba514
Annaba514 Jun. 18 at 5:50 PM
$LFMD always when HIMS goes up LFMD get destroyed. Weird.
1 · Reply
ClarissaLove
ClarissaLove Jun. 18 at 1:13 PM
$LFMD LifeMD is unraveling on two fronts: web traffic -55% y/y, and the app rank tumbled to #227 this week
0 · Reply
TaoistTrader
TaoistTrader Jun. 15 at 5:50 PM
$LFMD it’s that time of year for a break out
1 · Reply
Annaba514
Annaba514 Jun. 12 at 2:36 PM
$LFMD RUSSEL has moved up by 4% in 2 day however this thing didn't follow..
0 · Reply
Alex1965
Alex1965 Jun. 11 at 3:43 PM
$LFMD Another failed dump...
0 · Reply
Alex1965
Alex1965 Jun. 10 at 5:39 PM
$LFMD It's back up on very low volume with the broad market down for 2 days. So what's up ? $5.50 - .75 next leg up ?? A couple of new developments pending near term. Monthly website visits are back up for the past 2 months, 28 and 24% respectively. But don't mind me , I'm just a pumper with a huge position on this stock. What I see as worst case scenario for Q2 is: 1. Revenue guidance met closer to the upper range or better. 2. Adj. EBITDA break even or close. 3. Positive Oper. cash flow of $2.5 to $3.0M 4. Minimum revenue guidance for Q3 of $54 to $56M. But what do I know right ??? GL and perform your own DD Long LFMD
1 · Reply
MarioAndretti
MarioAndretti Jun. 8 at 11:28 PM
$LFMD SLOW action but we should be trading at 8-9 by EOY
1 · Reply
Latest News on LFMD
LifeMD appoints Umesh Sripad as chief technology officer

2026-06-01T14:34:47.000Z - 23 days ago

LifeMD appoints Umesh Sripad as chief technology officer


LifeMD Appoints Umesh Sripad as Chief Technology Officer

Jun 1, 2026, 8:05 AM EDT - 23 days ago

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LFMDP


LifeMD Transcript: 16th Annual LD Micro Invitational Conference

May 19, 2026, 12:00 PM EDT - 5 weeks ago

LifeMD Transcript: 16th Annual LD Micro Invitational Conference


LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026, 8:00 AM EDT - 5 weeks ago

LifeMD to Participate in Upcoming Investor Conferences

LFMDP


LifeMD Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 6 weeks ago

LifeMD Slides: Investor presentation


LifeMD reports Q1 EPS (20c), consensus (12c)

2026-05-07T00:47:06.000Z - 7 weeks ago

LifeMD reports Q1 EPS (20c), consensus (12c)


LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M

2026-05-07T00:46:21.000Z - 7 weeks ago

LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M


LifeMD Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 7 weeks ago

LifeMD Earnings Call Transcript: Q1 2026


LifeMD Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 7 weeks ago

LifeMD Earnings release: Q1 2026


LifeMD Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 7 weeks ago

LifeMD Slides: Q1 2026


LifeMD Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 7 weeks ago

LifeMD Quarterly report: Q1 2026


LifeMD Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 7 weeks ago

LifeMD Reports First Quarter 2026 Results


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

LifeMD Proxy statement: Proxy filing


LifeMD management to meet with BTIG

2026-04-24T17:05:27.000Z - 2 months ago

LifeMD management to meet with BTIG


LifeMD now offering Foundayo from Eli Lilly

2026-04-10T12:26:19.000Z - 2 months ago

LifeMD now offering Foundayo from Eli Lilly

LLY


LifeMD announces launch of Wegovy subscription program

2026-03-31T14:25:15.000Z - 3 months ago

LifeMD announces launch of Wegovy subscription program

NVO


LifeMD management to meet virtually with B. Riley

2026-03-17T15:41:34.000Z - 3 months ago

LifeMD management to meet virtually with B. Riley


LifeMD upgraded to Outperform from Neutral at Mizuho

2026-03-16T08:40:05.000Z - 3 months ago

LifeMD upgraded to Outperform from Neutral at Mizuho


LifeMD price target raised to $10 from $8 at Freedom Capital

2026-03-12T14:11:07.000Z - 3 months ago

LifeMD price target raised to $10 from $8 at Freedom Capital


LifeMD price target raised to $10 from $9 at H.C. Wainwright

2026-03-11T10:15:39.000Z - 3 months ago

LifeMD price target raised to $10 from $9 at H.C. Wainwright


LifeMD Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings Call Transcript: Q4 2025


LifeMD Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

LifeMD Annual report: Q4 2025


LifeMD Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings release: Q4 2025


LifeMD Slides: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

LifeMD Slides: Q4 2025


LifeMD reports Q4 EPS 41c, consensus 3c

2026-03-09T20:21:55.000Z - 3 months ago

LifeMD reports Q4 EPS 41c, consensus 3c


LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M

2026-03-09T20:21:26.000Z - 3 months ago

LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M


LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M

2026-03-09T20:20:41.000Z - 3 months ago

LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M


LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mar 9, 2026, 4:05 PM EDT - 3 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMDP


LifeMD closes $50M revolving credit facility

2026-01-06T13:47:34.000Z - 6 months ago

LifeMD closes $50M revolving credit facility


LifeMD Earnings Call Transcript: Q3 2025

Nov 17, 2025, 4:30 PM EST - 7 months ago

LifeMD Earnings Call Transcript: Q3 2025


LifeMD Quarterly report: Q3 2025

Nov 17, 2025, 4:30 PM EST - 7 months ago

LifeMD Quarterly report: Q3 2025


LifeMD Earnings release: Q3 2025

Nov 17, 2025, 4:30 PM EST - 7 months ago

LifeMD Earnings release: Q3 2025


LifeMD Slides: Q3 2025

Nov 17, 2025, 4:30 PM EST - 7 months ago

LifeMD Slides: Q3 2025


LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 7 months ago

LifeMD Reports Third Quarter 2025 Results

LFMDP


LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 8 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMDP


alphawolftrading
alphawolftrading Jun. 23 at 10:21 PM
$LFMD I just sat down again with LifeMD (NASDAQ: LFMD) Co‑Founder & CEO Justin Schreiber for a deep dive into how they’re building a full‑stack virtual healthcare and pharmacy platform – not just a GLP‑1 story. We cover their revamped leadership team, the LifeMD+ $19/month membership model for 24/7 primary and urgent care, upcoming Medicare GLP‑1 access at a $50 copay, and how AI, women’s and men’s health, metabolic programs, and personalized compounding fit into LifeMD’s next phase of growth. https://youtu.be/SfvC-JAFO4M
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 9:36 PM
$LFMD Back to the 3s like it never left. Does anyone here have a legitimate bull case that they can kindly share ?
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 2:09 PM
0 · Reply
Annaba514
Annaba514 Jun. 18 at 5:50 PM
$LFMD always when HIMS goes up LFMD get destroyed. Weird.
1 · Reply
ClarissaLove
ClarissaLove Jun. 18 at 1:13 PM
$LFMD LifeMD is unraveling on two fronts: web traffic -55% y/y, and the app rank tumbled to #227 this week
0 · Reply
TaoistTrader
TaoistTrader Jun. 15 at 5:50 PM
$LFMD it’s that time of year for a break out
1 · Reply
Annaba514
Annaba514 Jun. 12 at 2:36 PM
$LFMD RUSSEL has moved up by 4% in 2 day however this thing didn't follow..
0 · Reply
Alex1965
Alex1965 Jun. 11 at 3:43 PM
$LFMD Another failed dump...
0 · Reply
Alex1965
Alex1965 Jun. 10 at 5:39 PM
$LFMD It's back up on very low volume with the broad market down for 2 days. So what's up ? $5.50 - .75 next leg up ?? A couple of new developments pending near term. Monthly website visits are back up for the past 2 months, 28 and 24% respectively. But don't mind me , I'm just a pumper with a huge position on this stock. What I see as worst case scenario for Q2 is: 1. Revenue guidance met closer to the upper range or better. 2. Adj. EBITDA break even or close. 3. Positive Oper. cash flow of $2.5 to $3.0M 4. Minimum revenue guidance for Q3 of $54 to $56M. But what do I know right ??? GL and perform your own DD Long LFMD
1 · Reply
MarioAndretti
MarioAndretti Jun. 8 at 11:28 PM
$LFMD SLOW action but we should be trading at 8-9 by EOY
1 · Reply
StockPitcher
StockPitcher Jun. 8 at 8:42 PM
$LFMD Selling some covered calls at $7 for the July expiration date. The lack of growth is troubling me, I’m not as bullish as I once was
1 · Reply
Alex1965
Alex1965 Jun. 8 at 7:55 PM
$LFMD Any news dropping soon ???
1 · Reply
Alex1965
Alex1965 Jun. 5 at 5:54 PM
$LFMD https://seekingalpha.com/news/4601091-glp-1-sales-forecast-raised-150b-td-cowen?mailingid=46033311&messageid=2900&position=rta_news_bankrate_ad_rotation_main_2_textlink&serial=46033311.10380&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=46033311.10380
0 · Reply
TaoistTrader
TaoistTrader Jun. 5 at 2:08 PM
$LFMD strong
0 · Reply
ClarissaLove
ClarissaLove Jun. 5 at 1:51 PM
$LFMD When international expansion and peptides ?
0 · Reply
MarioAndretti
MarioAndretti Jun. 5 at 1:56 AM
$HYLN how you like that shit dumb fucking bears exposed as shit traders I’m 100% accurate on my traders $LFMD $SPY
0 · Reply
MarioAndretti
MarioAndretti Jun. 4 at 9:33 PM
$LFMD $HYLN cha ching
0 · Reply
TaoistTrader
TaoistTrader Jun. 4 at 3:31 PM
$LFMD traded at 14.76 last June remember?
0 · Reply
TaoistTrader
TaoistTrader Jun. 3 at 11:17 AM
$LFMD getting primed for break out
0 · Reply
LeeEnnisEA
LeeEnnisEA Jun. 2 at 6:54 PM
$LFMD found decent premium in July for $7.00 🤗
1 · Reply
rolypoly101
rolypoly101 Jun. 2 at 3:00 PM
$LFMD The price action on this looks like it's building up for another big run. Also looking at the 5 year chart, looks to be about time for the next rise. If Q2 shows positive EBITA and a rev beat, I think we're set for another run.
0 · Reply
MarioAndretti
MarioAndretti Jun. 2 at 2:37 PM
$LFMD cha Ching
0 · Reply